17 results
8-K
EX-10.1
TSHA
Taysha Gene Therapies Inc
14 Aug 23
Entry into a Material Definitive Agreement
7:29am
with all privacy laws applicable to the Company.
2.30 Clinical Data and Regulatory Compliance. The preclinical studies and clinical trials being conducted
8-K/A
EX-10.2
TSHA
Taysha Gene Therapies Inc
31 Oct 22
Entry into a Material Definitive Agreement
8:45am
or transaction, is or was the subject of Sanctions.
2.22 Data Privacy. The Company (i) has complied and is presently in compliance, each in all material … respects, with all internal and externally published privacy policies, contractual obligations, industry standards by which the Company is legally
8-K
EX-1.1
TSHA
Taysha Gene Therapies Inc
27 Oct 22
Taysha Announces Pricing of Public Offering of Common Stock
5:18pm
, with all internal and externally published privacy policies, contractual obligations, industry standards by which the Company is legally or contractually
S-3
EX-1.2
rmuce52tfs9lz2h1il9h
5 Oct 21
Shelf registration
5:04pm
10-K
5nthc8vcmkmf54i
3 Mar 21
Annual report
9:00am
10-Q
xaym68lu1m94zf
12 Nov 20
Quarterly report
4:27pm
424B4
tndovf2tsjdh8
25 Sep 20
Prospectus supplement with pricing info
12:00am
S-1/A
sqe2jdua46bb olx
8 Sep 20
IPO registration (amended)
4:43pm
S-1
3getokr00zewot6pmwj
2 Sep 20
IPO registration
5:02pm
DRS
dx76ms0
3 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next